Originator Organization |
Active Organization- |
Drug Highest PhasePendingNDA/BLA |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | NDA/BLA | CN | 05 Dec 2003 | |
Neoplasms | NDA/BLA | CN | 05 Dec 2003 | |
Neoplasms | NDA/BLA | CN | 05 Dec 2003 |